Loading...

Home
Stock
AKTX

AKTX News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AKTX News

SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm

2d agoNASDAQ.COM

U.S. Stocks Reach Record Highs as Investor Optimism Grows

2d agostocktwits

Akari Therapeutics Shows Promising Cancer Treatment Progress

2d agostocktwits

Akari Therapeutics Showcases Promising ASCO Data on AKTX-101

3d agoNewsfilter

Biotech Stocks Surge with Akari Leading the Rally

5d agoNASDAQ.COM

Biotech Sector Attracts Investor Attention Amid Innovation

May 22 2026Globenewswire

Akari Therapeutics Shares Surge Over 100% on Breakthrough Data

May 22 2026NASDAQ.COM

Akari's Cancer Therapy Data Sparks 120% Stock Surge

May 22 2026seekingalpha

AKTX Events

Akari Therapeutics Trading Halted Due to Volatility

Akari Therapeutics trading halted, volatility trading pause

Akari Therapeutics Trading Halted Due to Volatility

Akari Therapeutics trading halted, volatility trading pause

AKTX Monitor News

Akari Therapeutics Advances AKTX-101 with Promising ASCO Data

Akari Therapeutics' AKTX-101 Shows Promise in Cancer Treatment

Akari Therapeutics' AKTX-101 Shows Promise, Stock Surges

Akari Therapeutics Shares Surge Over 100% on Breakthrough Data

Akari Therapeutics Raises $5.5 Million for ADC Program

Akari Therapeutics reaches 20-day high amid market decline

Akari Therapeutics rises as it crosses above 5-day SMA

Akari Therapeutics raises $5M for oncology development

AKTX Earnings Analysis

No Data

No Data

People Also Watch